Trial intelligence / Profile preview

Effects of opioid analgesics on driving ability of pain patients

2009-011774-15Phase 4Completed

Sponsor
Bundesanstalt für Straßenwesen
Start
Jun 2009
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of fentanyl, buprenorphine and oxycodone in Chronic non-cancer pain (CNCP) (3 arms), sponsored by Bundesanstalt für Straßenwesen. Primary endpoint: Driving test performance. Started Jun 2009; status: completed.

02

Drugs

fentanylbuprenorphineoxycodone
03

Conditions

Chronic non-cancer pain (CNCP)

Beyond the preview

Go deeper on 2009-011774-15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-011774-15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call